Figure 3

Validation of the prognostic signature in GSE17536 and GSE24551 cohort. (A, B) Kaplan–Meier survival analysis for GEO-CRC patients with high and low risk scores. (C, D) Risk score distribution and survival status for GEO-CRC patients in high-risk and low-risk groups.